The GSA Implementation Working Group plans meeting alongside annual RPRG meeting to assist countries to access praziquantel drug donation programme
SCI and RTI are the co-chairs of the Global Schistosomiasis Alliance’s ‘Implementation Working Group’. The GSA’s Implementation Working Group is determined to assist countries to benefit from and make efficient use of the Merck KGaA praziquantel donation. The aim is to assist countries to implement treatment as appropriate for their country’s needs and capacity.
The GSA Implementation Working Group plans to host a meeting of the four World Health Organization (WHO) priority countries (DRC, Ethiopia, Nigeria, Tanzania) and a further 5 others (Côte d’Ivoire, Malawi, Mozambique, Sudan, Uganda), alongside the annual Regional Programme Review Group (RPRG) meeting at the beginning of October in Benin. Please click here for more details about the meeting.
The RPRG receives and considers applications from countries for drugs donated by GlaxoSmithKline, Johnson & Johnson, Merck and Merck KGaA.
For more information contact schisto@imperial.ac.uk
Article text (excluding photos or graphics) available under an Attribution-NonCommercial-ShareAlike Creative Commons license.
Photos and graphics subject to third party copyright used with permission or © Imperial College London.
Reporter
Mrs Alexandra Grainger
School of Public Health
Contact details
Email: press.office@imperial.ac.uk
Show all stories by this author
